{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:53:44Z","timestamp":1778903624871,"version":"3.51.4"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1097\/aog.0000000000000095","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T09:09:19Z","timestamp":1389172159000},"page":"295-303","source":"Crossref","is-referenced-by-count":22,"title":["Low-Dose Levonorgestrel and Ethinyl Estradiol Patch and Pill"],"prefix":"10.1097","volume":"123","author":[{"given":"Andrew M.","family":"Kaunitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Portman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn L.","family":"Westhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel R.","family":"Mishell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arkady","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Foegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210126","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/0091270006297919","article-title":". Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive.","volume":"47","author":"Devineni","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"R2-11-20210126","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive.","volume":"72","author":"van den Heuvel","year":"2005","journal-title":"Contraception"},{"key":"R3-11-20210126","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.AOG.0000250968.82370.04","article-title":"Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.","volume":"109","author":"Cole","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R4-11-20210126","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.contraception.2003.10.006","article-title":"The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy.","volume":"69","author":"Archer","year":"2004","journal-title":"Contraception"},{"key":"R5-11-20210126","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.contraception.2011.10.006","article-title":"Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial.","volume":"85","author":"Archer","year":"2012","journal-title":"Contraception"},{"key":"R6-11-20210126","first-page":"231","article-title":"Pharmacokinetics, tolerability and cycle control of three transdermal contraceptive delivery systems containing different doses of ethinyl estradiol and levonorgestrel.","volume":"6","author":"Stanczyk","year":"2011","journal-title":"Horm Mol Biol Clin Invest"},{"key":"R7-11-20210126","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(01)18648-4","article-title":"Factors in human fertility and their statistical evaluation.","volume":"222","author":"Pearl","year":"1933","journal-title":"Lancet"},{"key":"R8-11-20210126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jchromb.2006.12.052","article-title":"A semi-automated 96-well plate method for the simultaneous determination of oral contraceptives concentrations in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry.","volume":"852","author":"Licea-Perez","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R9-11-20210126","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2012.39","article-title":"Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.","volume":"307","author":"Flegal","year":"2012","journal-title":"JAMA"},{"key":"R10-11-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2005.04.002","article-title":"Family planning for obese women: challenges and opportunities.","volume":"72","author":"Grimes","year":"2005","journal-title":"Contraception"},{"key":"R11-11-20210126","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.contraception.2009.08.001","article-title":"Contraceptive considerations in obese women: release date 1 September 2009, SFP Guideline 20091.","volume":"80","author":"Society of Family Planning, Higginbotham","year":"2009","journal-title":"Contraception"},{"key":"R12-11-20210126","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.contraception.2013.04.001","article-title":"The creeping pearl: why has the rate of contraceptive failure increased in clinical trials of combined hormonal contraceptive pills C","volume":"88","author":"Trussell","year":"2013","journal-title":"ontraception"},{"key":"R13-11-20210126","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/jama.285.18.2347","article-title":"; ORTHO EVRAEVRA 004 Study Group. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial.","volume":"285","author":"Audet","year":"2001","journal-title":"JAMA"},{"key":"R14-11-20210126","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0010-7824(01)00214-1","article-title":". Comparison of a novel norgestimateethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 120.","volume":"63","author":"Hampton","year":"2001","journal-title":"Contraception"},{"key":"R15-11-20210126","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(03)00141-0","article-title":"A multicenter, randomized study of an extended cycle oral contraceptive.","volume":"68","author":"Anderson","year":"2003","journal-title":"Contraception"},{"key":"R16-11-20210126","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States.","volume":"83","author":"Trussel","year":"2011","journal-title":"Contraception"},{"key":"R17-11-20210126","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/AOG.0b013e3181e79440","article-title":". Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial.","volume":"116","author":"Westhoff","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R18-11-20210126","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/jech.2009.096297","article-title":"Social context explains race disparities in obesity among women.","volume":"64","author":"Bleich","year":"2010","journal-title":"J Epidemiol Community Health"},{"issue":"suppl 2","key":"R19-11-20210126","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0015-0282(01)03275-7","article-title":"Contraceptive efficacy and cycle control with the Ortho EvraEvra transdermal system: the analysis of pooled data.","volume":"77","author":"Zieman","year":"2002","journal-title":"Fertil Steril"},{"key":"R20-11-20210126","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.contraception.2007.10.012","article-title":"The relationship between body mass index and unintended pregnancy: results from the 2002 National Survey of Family Growth.","volume":"77","author":"Kaneshiro","year":"2008","journal-title":"Contraception"},{"key":"R21-11-20210126","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.contraception.2011.08.001","article-title":"Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive.","volume":"85","author":"Westhoff","year":"2012","journal-title":"Contraception"},{"key":"R22-11-20210126","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.contraception.2012.08.042","article-title":"Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgestrel.","volume":"87","author":"Foegh","year":"2013","journal-title":"Contraception"},{"key":"R24-11-20210126","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.contraception.2006.12.003","article-title":"Treatment satisfaction with a transdermal contraceptive patch or oral contraceptives.","volume":"75","author":"Wan","year":"2007","journal-title":"Contraception"},{"key":"R25-11-20210126","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1056\/NEJMe1204769","article-title":"Hormonal contraceptives and arterial thrombosisnot risk-free but safe enough.","volume":"366","author":"Petitti","year":"2012","journal-title":"N Engl J Med"},{"key":"R26-11-20210126","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1161\/01.CIR.0000031705.57473.1C","article-title":"Upper-extremity deep vein thrombosis.","volume":"106","author":"Joffe","year":"2002","journal-title":"Circulation"},{"key":"R27-11-20210126","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2141.2007.06780.x","article-title":"Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations.","volume":"139","author":"Pomp","year":"2007","journal-title":"Br J Haematol"},{"key":"R28-11-20210126","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/bmj.280.6224.1157","article-title":"Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.","volume":"280","author":"Meade","year":"1980","journal-title":"Br Med J"},{"key":"R29-11-20210126","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.contraception.2012.09.015","article-title":". Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.","volume":"87","author":"Sidney","year":"2013","journal-title":"Contraception"}],"container-title":["Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000000095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:16:38Z","timestamp":1620944198000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201402000-00011"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000000095","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}